69796-18-5 Usage
Uses
Used in Pharmaceutical Industry:
[8-chloro-2-(4-chlorophenyl)quinolin-4-yl](piperidin-2-yl)methanol is used as a potential drug candidate for the development of new medications. Its unique structural features allow it to interact with specific biological targets, which may be beneficial in the treatment of various diseases. [8-chloro-2-(4-chlorophenyl)quinolin-4-yl](piperidin-2-yl)methanol's potential applications in medicinal chemistry are still under investigation, and further research is required to fully understand its biological activities and therapeutic potential.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, [8-chloro-2-(4-chlorophenyl)quinolin-4-yl](piperidin-2-yl)methanol serves as a valuable compound for studying its interactions with biological targets. This research may lead to the discovery of new drugs or therapies for a range of diseases. [8-chloro-2-(4-chlorophenyl)quinolin-4-yl](piperidin-2-yl)methanol's structural versatility and potential pharmacological properties make it an attractive candidate for further exploration and development in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 69796-18-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,7,9 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 69796-18:
(7*6)+(6*9)+(5*7)+(4*9)+(3*6)+(2*1)+(1*8)=195
195 % 10 = 5
So 69796-18-5 is a valid CAS Registry Number.
69796-18-5Relevant academic research and scientific papers
COMPOUNDS AND USE FOR TREATING CANCER
-
, (2016/08/17)
The present invention relates to certain 2,4-disubstituted quinoline derivatives, to their therapy, as well as to pharmaceutical compositions comprising said compounds. More specifically the invention relates to certain 2,4-disubstituted quinoline derivatives or pharmaceutical compositions comprising said compounds for the treatment of cancers characterized by overactive Ras and/or Rac or signalling pathway.
